TABLE 1.
Overview of the descriptive statistics of the included patient sample.
| Survivors (n = 10) | Nonsurvivors (n = 12) | p | |
|---|---|---|---|
| Gender (female, %) | 5 (50) | 5 (42) | 0.77 |
| Age, years | 71.90 ± 7.40 | 71.67 ± 10.07 | 0.87 |
| Bismuth classification | 0.82 | ||
| I | 0 | 0 | |
| II | 0 | 1 | |
| IIIA | 1 | 0 | |
| IIIB | 0 | 1 | |
| IV | 9 | 10 | |
| Grading | |||
| I | 0 | 1 | |
| II | 8 | 9 | |
| III | 2 | 2 | |
| pT | 0.08 | ||
| pT1a | 0 | 1 | |
| pT1b | 0 | 2 | |
| pT2a | 2 | 5 | |
| pT2b | 6 | 2 | |
| pT3 | 1 | 1 | |
| pT4 | 1 | 1 | |
| N | 0.38 | ||
| N0 | 5 | 8 | |
| N1 | 3 | 4 | |
| N2 | 2 | 0 | |
| M | 0.77 | ||
| M0 | 10 | 11 | |
| M1 | 0 | 1 | |
| Preoperative bilirubine (μmol/L) | 11.1 ± 3.1 | 34.5 ± 16.7 | 0.03 |
| Preoperative prothrombin time (%) | 86.5 ± 20.5 | 86.8 ± 16.6 | 0.92 |
| Preoperative CEA (μg/L) | 1.9 ± 0.4 | 4.6 ± 5.9 | 0.83 |
| Preoperative CA 19‐9 (μ/mL) | 111.5 ± 38.8 | 221.1 ± 163.4 | 0.66 |
| Preoperative AFP (μg/L) | 2.4 ± 0.8 | 10.2 ± 17.7 | 0.29 |
Note: Bold indicates significant values.